Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent

Journal of Immunology

Volumn 193, Issue 11, 2014, Pages 5498-5505

  Liang, Dongchun ^a   Zuo, Aijun ^a   Shao, Hui ^b   Chen, Mingjiazi ^a   Kaplan, Henry J ^b   Sun, Deming ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2 RECEPTOR AGONIST; BAY 60 6538; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR STIMULATING AGENT; ANTIINFLAMMATORY AGENT; AUTACOID; AUTOANTIGEN; EYE PROTEIN; INTERSTITIAL RETINOL-BINDING PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT; RETINOL BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE UVEITIS; AUTOIMMUNITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GAMMA DELTA T LYMPHOCYTE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; ANIMAL; AUTOIMMUNE DISEASES; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; UVEITIS;

ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; ANTI-INFLAMMATORY AGENTS; AUTOANTIGENS; AUTOIMMUNE DISEASES; CELLS, CULTURED; EYE PROTEINS; FEMALE; HUMANS; IMMUNOMODULATION; INFLAMMATION MEDIATORS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, ANIMAL; PEPTIDE FRAGMENTS; PURINERGIC P1 RECEPTOR AGONISTS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RETINOL-BINDING PROTEINS; TH1 CELLS; TH17 CELLS; UVEITIS;

EID: 84912550490     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401959     Document Type: Article

References (51)

1. Colgan, S. P., H. K. Eltzschig, T. Eckle, and L. F. Thompson. 2006. Physiological roles for ecto-59-nucleotidase (CD73). Purinergic Signal. 2: 351-360.
2. Thompson, L. F., H. K. Eltzschig, J. C. Ibla, C. J. Van De Wiele, R. Resta, J. C. Morote-Garcia, and S. P. Colgan. 2004. Crucial role for ecto-59-nucleotidase (CD73) in vascular leakage during hypoxia. J. Exp. Med. 200: 1395-1405.
3. Blackburn, M. R., J. B. Volmer, J. L. Thrasher, H. Zhong, J. R. Crosby, J. J. Lee, and R. E. Kellems. 2000. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J. Exp. Med. 192: 159-170.
4. Blackburn, M. R., and R. E. Kellems. 2005. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv. Immunol. 86: 1-41.
5. Jacobson, K. A., and Z.-G. Gao. 2006. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5: 247-264.
6. Feoktistov, I., and I. Biaggioni. 1997. Adenosine A2B receptors. Pharmacol. Rev. 49: 381-402.
7. Mandler, R., R. E. Birch, S. H. Polmar, G. M. Kammer, and S. A. Rudolph. 1982. Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 79: 7542-7546.
8. Mills, J. H., L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe. 2008. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 105: 9325-9330.
9. Niemelä, J., I. Ifergan, G. G. Yegutkin, S. Jalkanen, A. Prat, and L. Airas. 2008. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. Eur. J. Immunol. 38: 2718-2726.
10. Ramlackhansingh, A. F., S. K. Bose, I. Ahmed, F. E. Turkheimer, N. Pavese, and D. J. Brooks. 2011. Adenosine 2A receptor availability in dyskinetic and nondyskinetic patients with Parkinson disease. Neurology 76: 1811-1816.
11. Zaynagetdinov, R., S. Ryzhov, A. E. Goldstein, H. Yin, S. V. Novitskiy, K. Goleniewska, V. V. Polosukhin, D. C. Newcomb, D. Mitchell, E. Morschl, et al. 2010. Attenuation of chronic pulmonary inflammation in A2B adenosine receptor knockout mice. Am. J. Respir. Cell Mol. Biol. 42: 564-571.
12. Linden, J. 2006. New insights into the regulation of inflammation by adenosine. J. Clin. Invest. 116: 1835-1837.
13. Hasko, G., B. Csoka, Z. H. Nemeth, E. S. Vizi, and P. Pacher. 2009. A2B adenosine receptors in immunity and inflammation. Trends Immunol. 30: 263-270.
14. Blackburn, M., C. Vance, E. Morschl, and C. Wilson. 2009. Adenosine receptors and inflammation. In Adenosine Receptors in Health and Disease. C. N. Wilson and S. J. Mustafa, eds. Springer-Verlag, Berlin, Germany, p. 215-269.
15. Odashima, M., G. Bamias, J. Rivera-Nieves, J. Linden, C. C. Nast, C. A. Moskaluk, M. Marini, K. Sugawara, K. Kozaiwa, M. Otaka, et al. 2005. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology 129: 26-33.
16. Alam, M. S., C. C. Kurtz, J. M. Wilson, B. R. Burnette, E. B. Wiznerowicz, W. G. Ross, J. M. Rieger, R. A. Figler, J. Linden, S. E. Crowe, and P. B. Ernst. 2009. A2A adenosine receptor (AR) activation inhibits pro-inflammatory cytokine production by human CD4+ helper T cells and regulates Helicobacter-induced gastritis and bacterial persistence. Mucosal Immunol. 2: 232-242.
17. Kolachala, V. L., M. Vijay-Kumar, G. Dalmasso, D. Yang, J. Linden, L. Wang, A. Gewirtz, K. Ravid, D. Merlin, and S. V. Sitaraman. 2008. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology 135: 861-870.
18. Belikoff, B. G., L. J. Vaickus, M. Sitkovsky, and D. G. Remick. 2012. A2B adenosine receptor expression by myeloid cells is proinflammatory in murine allergic-airway inflammation. J. Immunol. 189: 3707-3713.
19. Wilson, J. M., C. C. Kurtz, S. G. Black, W. G. Ross, M. S. Alam, J. Linden, and P. B. Ernst. 2011. The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6. J. Immunol. 186: 6746-6752.
20. Wei, W., C. Du, J. Lv, G. Zhao, Z. Li, Z. Wu, G. Haskó, and X. Xie. 2013. Blocking A2B adenosine receptor alleviates pathogenesis of experimental autoimmune encephalomyelitis via inhibition of IL-6 production and Th17 differentiation. J. Immunol. 190: 138-146.
21. Mills, J. H., D. G. Kim, A. Krenz, J. F. Chen, and M. S. Bynoe. 2012. A2A adenosine receptor signaling in lymphocytes and the central nervous system regulates inflammation during experimental autoimmune encephalomyelitis. J. Immunol. 188: 5713-5722.
22. Nian, H., H. Shao, G. Zhang, W. K. Born, R. L. O'Brien, H. J. Kaplan, and D. Sun. 2010. Regulatory effect of gammadelta T cells on IL-17+ uveitogenic T cells. Invest. Ophthalmol. Vis. Sci. 51: 4661-4667.
23. Nian, H., H. Shao, R. L. O'Brien, W. K. Born, H. J. Kaplan, and D. Sun. 2011. Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development. Invest. Ophthalmol. Vis. Sci. 52: 5920-5927.
24. Liang, D., A. Zuo, H. Shao, W. K. Born, R. L. O'Brien, H. J. Kaplan, and D. Sun. 2012. Role of CD25+ dendritic cells in the generation of Th17 autoreactive T cells in autoimmune experimental uveitis. J. Immunol. 188: 5785-5791.
25. Liang, D., A. Zuo, H. Shao, W. K. Born, R. L. O'Brien, H. J. Kaplan, and D. Sun. 2013. IL-23 receptor expression on γδ T cells correlates with their enhancing or suppressive effects on autoreactive T cells in experimental autoimmune uveitis. J. Immunol. 191: 1118-1125.
26. Liang, D., A. Zuo, H. Shao, M. Chen, H. J. Kaplan, and D. Sun. 2014. Roles of the adenosine receptor and CD73 in the regulatory effect of γδ T cells. PLoS One. 30: e108932
27. Peng, Y., G. Han, H. Shao, Y. Wang, H. J. Kaplan, and D. Sun. 2007. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 48: 4153-4161.
28. Cui, Y., H. Shao, C. Lan, H. Nian, R. L. O'Brien, W. K. Born, H. J. Kaplan, and D. Sun. 2009. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J. Immunol. 183: 560-567.
29. Zuo, A., D. Liang, H. Shao, W. K. Born, H. J. Kaplan, and D. Sun. 2012. In vivo priming of IL-17(+) uveitogenic T cells is enhanced by Toll ligand receptor (TLR)2 and TLR4 agonists via γδ T cell activation. Mol. Immunol. 50: 125-133.
30. Sun, D., D. B. Wilson, L. Cao, and J. N. Whitaker. 1998. The role of regulatory T cells in Lewis rats resistant to EAE. J. Neuroimmunol. 81: 177-183.
31. Fischer, H. P., C. E. M. Sharrock, M. J. Colston, and G. S. Panayi. 1991. Limiting dilution analysis of proliferative T cell responses to mycobacterial 65-kDa heatshock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis. Eur. J. Immunol. 21: 2937-2941.
32. Thurau, S. R., C. C. Chan, R. B. Nussenblatt, and R. R. Caspi. 1997. Oral tolerance in a murine model of relapsing experimental autoimmune uveoretinitis (EAU): induction of protective tolerance in primed animals. Clin. Exp. Immunol. 109: 370-376.
33. Shao, H., T. Liao, Y. Ke, H. Shi, H. J. Kaplan, and D. Sun. 2006. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells. Exp. Eye Res. 82: 323-331.
34. Liang, D., A. Zuo, H. Shao, W. K. Born, R. L. O'Brien, H. J. Kaplan, and D. Sun. 2013. Retinoic acid inhibits CD25+ dendritic cell expansion and γδ T-cell activation in experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 54: 3493-3503.
35. Fredholm, B. B., A. P. IJzerman, K. A. Jacobson, K. N. Klotz, and J. Linden. 2001. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53: 527-552.
36. Zarek, P. E., C.-T. Huang, E. R. Lutz, J. Kowalski, M. R. Horton, J. Linden, C. G. Drake, and J. D. Powell. 2008. A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. Blood 111: 251-259.
37. Ohta, A., and M. Sitkovsky. 2001. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
38. Kolachala, V., B. Ruble, M. Vijay-Kumar, L. Wang, S. Mwangi, H. Figler, R. Figler, S. Srinivasan, A. Gewirtz, J. Linden, et al. 2008. Blockade of adenosine A2B receptors ameliorates murine colitis. Br. J. Pharmacol. 155: 127-137.
39. Sun, C.-X., H. Zhong, A. Mohsenin, E. Morschl, J. L. Chunn, J. G. Molina, L. Belardinelli, D. Zeng, and M. R. Blackburn. 2006. Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J. Clin. Invest. 116: 2173-2182.
40. Schingnitz, U., K. Hartmann, C. F. Macmanus, T. Eckle, S. Zug, S. P. Colgan, and H. K. Eltzschig. 2010. Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury. J. Immunol. 184: 5271-5279.
41. Zhou, Y., A. Mohsenin, E. Morschl, H. W. J. Young, J. G. Molina, W. Ma, C. X. Sun, H. Martinez-Valdez, and M. R. Blackburn. 2009. Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor. J. Immunol. 182: 8037-8046.
42. Sevigny, C. P., L. Li, A. S. Awad, L. Huang, M. McDuffie, J. Linden, P. I. Lobo, and M. D. Okusa. 2007. Activation of adenosine 2A receptors attenuates allograft rejection and alloantigen recognition. J. Immunol. 178: 4240-4249.
43. Nian, H., D. Liang, A. Zuo, R. Wei, H. Shao, W. K. Born, H. J. Kaplan, and D. Sun. 2012. Characterization of autoreactive and bystander IL-17+ T cells induced in immunized C57BL/6 mice. Invest. Ophthalmol. Vis. Sci. 53: 897-905.
44. Rubtsov, Y. P., R. E. Niec, S. Josefowicz, L. Li, J. Darce, D. Mathis, C. Benoist, and A. Y. Rudensky. 2010. Stability of the regulatory T cell lineage in vivo. Science 329: 1667-1671.
45. Sakaguchi, S., D. A. A. Vignali, A. Y. Rudensky, R. E. Niec, and H. Waldmann. 2013. The plasticity and stability of regulatory T cells. Nat. Rev. Immunol. 13: 461-467.
46. Josefowicz, S. Z., L.-F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531-564.
47. Barbi, J., D. Pardoll, and F. Pan. 2014. Treg functional stability and its responsiveness to the microenvironment. Immunol. Rev. 259: 115-139.
48. Haskó, G., J. Linden, B. Cronstein, and P. Pacher. 2008. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat. Rev. Drug Discov. 7: 759-770.
49. Eltzschig, H. K., J. C. Ibla, G. T. Furuta, M. O. Leonard, K. A. Jacobson, K. Enjyoji, S. C. Robson, and S. P. Colgan. 2003. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198: 783-796.
50. Lennon, P. F., C. T. Taylor, G. L. Stahl, and S. P. Colgan. 1998. Neutrophilderived 59-adenosine monophosphate promotes endothelial barrier function via CD73-mediated conversion to adenosine and endothelial A2B receptor activation. J. Exp. Med. 188: 1433-1443.
51. Novitskiy, S. V., S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, Y. Huang, O. Y. Tikhomirov, M. R. Blackburn, I. Biaggioni, D. P. Carbone, I. Feoktistov, and M. M. Dikov. 2008. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112: 1822-1831.